10 Bristol Myers Squibb business development leaders

These ten Bristol Myers Squibb business development leaders hold senior director and executive director roles in business development transactions, search and evaluation, global alliances and divestitures at Bristol Myers Squibb. A reader can learn how business development leaders work at Bristol Myers Squibb from people who have held the role.

10 professionals1 companyData retrieved October 9, 2026

Professionals to explore

  1. David Boyko

    LinkedIn

    Experience: Senior Director, Business Development, Transactions (Oncology Hematology & Cell Therapy) · Bristol Myers Squibb

    Senior Director, Business Development, Transactions (Oncology Hematology & Cell Therapy) at Bristol Myers Squibb since October 2021. His profile describes him as a lawyer and business development director; he was earlier Director, Global Business Development at Merck Animal Health and Executive Director, Corporate Transactions at Merck.

    Is this you? Claim your profile and get paid for calls.

  2. James Yang

    LinkedIn

    Experience: Senior Director, Global Alliances | Strategy and Business Development · Bristol Myers Squibb

    Senior Director, Global Alliances | Strategy and Business Development at Bristol Myers Squibb since February 2026, after Director and Associate Director roles in the same group from 2020. His profile describes overseeing collaborations with external partners, including joint governance, key collaboration initiatives and conflict resolution.

    Is this you? Claim your profile and get paid for calls.

  3. Joseph P. Simeone

    LinkedIn

    Experience: Executive Director, Search & Evaluation, Immunology, Cardiovascular & Neuroscience · Bristol Myers Squibb

    Executive Director, Search & Evaluation, Immunology, Cardiovascular & Neuroscience at Bristol Myers Squibb since April 2022. He previously held business development and licensing roles at Merck from 2012 to 2022, including Executive Director, Business Development & Licensing - Oncology; his profile notes both search and evaluation and transactional experience.

    Is this you? Claim your profile and get paid for calls.

  4. Linda Brennan

    LinkedIn

    Experience: Sr. Director, Business Development, Transactions · Bristol Myers Squibb

    Sr. Director, Business Development, Transactions at Bristol Myers Squibb since August 2020; her profile describes co-leading with search and evaluation and therapeutic area heads on business assessments of external opportunities. She was earlier Executive Director, Business Development & Licensing at Novartis and Executive Director, BD&L and Alliance Management Finance at Sandoz.

    Is this you? Claim your profile and get paid for calls.

  5. Matt Bunn

    LinkedIn

    Experience: Executive Director, Business Development and Licensing Transactions · Bristol Myers Squibb

    Executive Director, Business Development and Licensing Transactions at Bristol Myers Squibb since June 2025, after serving as Senior Director in the same group (2020–2025). He was earlier Director and Associate Director, Business Development, Technology Transactions at BMS from 2010 to 2020, after a project manager role in oncology and pharmacodiagnostics.

    Is this you? Claim your profile and get paid for calls.

  6. Meadow Green

    LinkedIn

    Experience: Senior Director, Business Development - Search and Evaluation · Bristol Myers Squibb

    Senior Director, Business Development - Search and Evaluation at Bristol Myers Squibb since January 2025, after serving as Senior Director, Early Asset and Business Development (Hematology & Oncology) from 2022 to 2025. She was earlier Head of Worldwide Access Innovation at BMS and a market access and pricing lead at ZS.

    Is this you? Claim your profile and get paid for calls.

  7. Nancy Dougherty

    LinkedIn

    Experience: Executive Director, Business Development Transactions · Bristol Myers Squibb

    Executive Director, Business Development Transactions at Bristol Myers Squibb since August 2024, where her profile describes leading transactions across therapeutic areas. She was earlier Senior Director (2020–2024) and Director (2016–2020) of Business Development Transactions at BMS, after Director and Associate Director roles in Business Development & Licensing at Merck.

    Is this you? Claim your profile and get paid for calls.

  8. Priya Sriraman

    LinkedIn

    Experience: Executive Director, Global Alliances, Strategy and Business Development · Bristol Myers Squibb

    Executive Director, Global Alliances, Strategy and Business Development at Bristol Myers Squibb since March 2021; her profile describes building strategic relationships with R&D collaboration partners to maximize the value of external innovation. She was earlier Senior Director, Business Development and Global Alliances at Celgene.

    Is this you? Claim your profile and get paid for calls.

  9. Sean O'Leary

    LinkedIn

    Experience: Executive Director, Divestitures and Out-Licensing Transactions · Bristol Myers Squibb

    Executive Director, Divestitures and Out-Licensing Transactions at Bristol Myers Squibb since February 2026, after serving as Senior Director, Divestitures - Corporate Development (2022–2026). He was earlier Director for divestitures, M&A and equity investments in BMS corporate development, and a director in global product development and supply business development.

    Is this you? Claim your profile and get paid for calls.

  10. Sévrine Broxer

    LinkedIn

    Experience: Senior Director, Business Development Transaction · Bristol Myers Squibb

    Senior Director, Business Development Transaction at Bristol Myers Squibb since March 2025, after serving as Director, Business Development Transaction, Oncology, Heme and Cell Therapy (2021–2025). Earlier BMS roles include Associate Director in business development transactions and in global manufacturing and supply business development.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

Match the person's scope to your question, since search and evaluation, licensing transactions, global alliance management and divestitures or out-licensing involve different work. Check which therapeutic area and deal type the person's role covers, since that shapes what they can speak to.

Questions to take into the conversation

  1. 01How do search and evaluation and transaction teams split work on a licensing deal?
  2. 02How does a pharmaceutical company govern a research collaboration after signing?
  3. 03How are divestitures and out-licensing deals run compared with in-licensing?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals